Peter A Lohse

Dr. Peter Lohse joined the Office of Corporate Relations (OCR) in October 2018 as Program Director.
 
Lohse comes to OCR with deep and broad knowledge and expertise in the pharma, biotech, and other life sciences-driven industries including agro, nutrition, chemical, and consumer products. As a scientist and entrepreneur, he has an extensive background developing business and managing partnerships with large corporations, early-stage companies, academia, and non-profit organizations. Most recently, Lohse was V.P, Operations and Business Development for InnovaTID Pharmaceuticals in Cambridge. Before that, he was a Strategy Consultant for Eutropics Pharmaceuticals, an emerging biotech company in Cambridge.

Prior to this, Dr. Lohse was Director, Scientific Operations & Innovation Program Director for Eli-Lilly’s open innovation platform, InnoCentive, Inc. in Waltham. Earlier in his career, he held positions with increasing responsibility at ArQule of Woburn, Phylos in Lexington, and Novartis Pharma in Switzerland.
 
Lohse earned his M.S., Chemistry & Applied Sciences and his Ph.D., Organic Chemistry at Federal institute of Technology (ETH) in Switzerland. He earned his M.B.A., Strategy, Finance, Marketing as a Sloan Fellow at MIT.  He also held the position Research Fellow, Molecular Biology at Harvard Medical School - Massachusetts General Hospital, Boston (with Professor J. Szostak, Nobel Prize 2009), This was a Swiss National Science Foundation Postdoctoral Fellowship -- In vitro selection of functional RNAs.
 
Lohse teaches his native German to > 400 children ages 5-17 and also speaks French (working proficiency), Italian (elementary proficiency) and Chinese (elementary proficiency).